Hints and tips:
...Aventis, which had US law firm Sullivan & Cromwell as a legal adviser, prepared a court challenge — but a new price was agreed and the deal went through....
...Sanofi and Aventis merged to take on US pharma, but have not caught Pfizer. Nor have Glaxo and SmithKline Beecham....
...Marconi, Warner-Lambert, BellSouth, Lehman Brothers, Cadbury, Rowntree, Mannesmann, Aventis — the rate at which familiar corporate names are disappearing or losing their independence has speeded up, driven...
...Expansion by larger drug companies was the norm at the start of this century, from the merger that created GlaxoSmithKline in 2000 and the $67bn purchase of Aventis by Sanofi in 2004, to Pfizer’s $68bn paid...
...Amgen, Sanofi-Aventis and Pfizer have all made acquisitions in this area in Brazil....
...Mr Soriot, 53, a Frenchman who trained as a veterinary surgeon before obtaining an MBA, worked for much of his career in Asia for Roussel Uclaf, Hoechst and Aventis, which became part of Sanofi in 2004....
...It was the largest bond sale in the US since March 2011, when Sanofi-Aventis sold $7bn, Dealogic said....
...That is good news for the backlog of other companies awaiting similar appeals, including brewer SABMiller, US wireless operator AT&T, and French drugmaker Sanofi-Aventis....
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
...Shire had little incentive to fund the extra tests as production at Genzyme, now owned by Sanofi-Aventis, would return to normal later this year, analysts said....
...Aventis Pharma seals deal to buy Universal Medicare Aventis Pharma, a part of French drug maker Sanofi has entered into a definitive agreement to acquire Universal Medicare’s marketing and distribution business...
...Sanofi-Aventis investors, meanwhile, will pore over the impact of its recently lost patents. Stepping back, investors should watch for the impact of recent government cuts to drug prices....
...For example, Sanofi-Aventis, the French multinational pharmaceutical company, is using Microsoft’s SharePoint to revamp its R&D process....
...action follows the arrests last year in Belgrade of senior officials at the Serbian Institute for Oncology and Radiology, as well as the heads of the Belgrade offices of AstraZeneca, Roche, Actavis, Sanofi-Aventis...
...Sanofi-Aventis plans to cut costs and expand its animal health business through acquisitions as it fully integrates Merial after the collapse of its longstanding joint venture with Merck of the US....
...Merck maintains a development and marketing partnership for vaccines in Europe with Sanofi-Aventis, and until the recent collapse of talks it was planning a renewal of Merial, its long-standing partnership...
...Sanofi-Aventis has continued aggressively to acquire others, including ultimately winning support for the takeover of US group Genzyme after raising its bid above $20bn....
...The CVR helped Sanofi-Aventis win its takeover bid, providing a way around protracted disagreements between Sanofi-Aventis and Genzyme that centred on the value of the US biotech group’s experimental drug...
...Sanofi-Aventis brought an end to its protracted pursuit of Genzyme with an agreed $20.1bn cash takeover of the US biotech company, coupled with additional conditional payments over the next decade, reports...
...Merck and Sanofi-Aventis have abandoned plans to create the world’s largest animal health company, scrapping a joint venture with combined sales of $5.5bn that was announced a year ago, in a move they blamed...
...Sanofi-Aventis cautioned that 2011 earnings were likely to be down by as much as 10 per cent from last year’s €7.06 ($9.68) a share as a result of increased pricing pressure and threats from generic competition...
...The deals this week included some large transactions to finance acquisitions, such as the $7bn sold by Sanofi-Aventis....
...He said that there could also be legal disputes over Sanofi-Aventis’ implementation of its pledge for “diligent efforts” to develop Lemtrada....
...Investors were also awaiting the announcement of a takeover of Genzyme , the US pharmaceuticals company, by its French competitor Sanofi-Aventis....
International Edition